AryoGen Pharmed (Persian: آریوژن فارمد) is an Iranian biopharmaceutical company specializing in manufacturing Therapeutic Monoclonal antibodies and some other recombinant proteins.

[1][2][3] AryoGen is a biopharmaceutical company created on the mandate of Iranian executive branch.

It was spun off a Biopharmaceutical company, which formed a new entity named AryoGen Pharmed which started its production in 2011.

AryoGen Pharmed (AryoGen) has received a Good Manufacturing Practice (GMP) certificate from the European Medicines Agency (EMA), becoming one of the first monoclonal antibody (mAb) manufacturers in the Middle East and North Africa (MENA) region to be certified.

[4] AryoGen's products include: AryoSeven is now approved by Iranian food and drug organisation and from August 2012 is in the market.